Evaluation of a Produce Prescription Program for Patients With Diabetes: A Longitudinal Analysis of Glycemic Control
Main finding · Change in HbA1cResult — go to the resultDifference 0.13 percentage points 95% CI −0.05 to 0.32Authors' conclusion
A 6-month produce prescription program for patients with diabetes, implemented during the onset of the COVID-19 pandemic, was not associated with improved glycemic control.
Study context
- Population
- Patients with diabetes from two clinics in Hartford, Connecticut; program implementation coincided with the start of the COVID-19 pandemic (March 2020)
- Participants
- 252 vs 534
- Exposure
- Produce prescription vs usual care
- Produce prescriptionn = 252
- Controln = 534reference
- Outcome
- Change in HbA1c between treatment and control
- Follow-up
- 6 months
Methodological detailsnonrandom enrollment, propensity score overlap weighting, generalized estimating equation models, two clinics
- Nonrandom enrollment
- Propensity score overlap weighting
- Generalized estimating equation models
- Two clinics
Main finding
Change in HbA1c
Difference
0.13 percentage points
95% CI −0.05 to 0.32
Produce prescriptionvs Control
difference 0.13 percentage points (95% CI −0.05 to 0.32)
As reported in the abstract
Observational data: associations, not effects.
Secondary outcomes
Change in SBP · 6 months
- No significant difference in change in SBP
- 3.85 mmHg; −0.12, 7.82 (difference; 95% CI)
- Propensity score overlap weighted GEE
Change in diastolic blood pressure (DBP) · 6 months
- No significant difference in change in DBP
- −0.82 mmHg; −2.42, 0.79 (difference; 95% CI)
- Propensity score overlap weighted GEE
Change in BMI · 6 months
- No significant difference in change in BMI
- −0.22 kg/m²; −1.83, 1.38 (difference; 95% CI)
- Propensity score overlap weighted GEE
Hospitalizations · 6 months
- IRR for hospitalizations
- 0.54 (0.14, 1.95) (95% CI)
ED visits · 6 months
- IRR for ED visits
- 0.53 (0.06, 4.72) (95% CI)
Original publication
Evaluation of a Produce Prescription Program for Patients With Diabetes: A Longitudinal Analysis of Glycemic Control. Diabetes Care. Published 22 February 2023. doi:10. 2337/ dc22-1645
Composed by AI from the published abstract and checked against it. How Briefs are made →